Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qu Feng Zhi Tong Capsule (祛风止痛胶囊) is an oral traditional Chinese patent medicine developed and manufactured by Shaanxi Buchang Pharmaceutical. [1] It is approved in China for treating rheumatoid arthritis and is also clinically studied for knee osteoarthritis. [14] In traditional Chinese medicine, it is used to expel wind-cold, supplement the liver and kidney, and strengthen muscles and bones to alleviate conditions like joint swelling, pain, and numbness. [1] The formula is derived from the ancient prescription "Duhuo Jisheng Tang". [1] Research indicates that the capsule exerts anti-inflammatory and immunomodulatory effects, potentially through the inhibition of pro-inflammatory cytokines such as TNF-alpha, IL-1β, and IL-6 via the MAPK and NF-κB signaling pathways. [2, 3, 8] Its ingredients include Erodium stephanianum, Viscum coloratum, Dipsacus asper, Clematis chinensis, Angelica pubescens, processed Aconite root, and Carthamus tinctorius. [1, 7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qu Feng Zhi Tong Capsule.